CV Sciences (CVSI) Other Non-Current Assets (2013 - 2026)
CV Sciences (CVSI) posted Other Non-Current Assets of $47000.0 for Q1 2026, little changed sequentially from $47000.0 in Q4 2025, and down 52.53% YoY from $99000.0 in Q1 2025.
CV Sciences (CVSI) Other Non-Current Assets (2013 - 2026) Analysis & Trends
CV Sciences has reported Other Non-Current Assets for 13 years, with the latest figure at $47000.0 in Q1 2026.
- Quarterly Other Non-Current Assets fell 52.53% year-over-year to $47000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $47000.0 (down 52.53% YoY) and the FY2025 annual result came in at $47000.0, changed N/A from the prior year.
- Other Non-Current Assets steadied at $47000.0 in Q1 2026 per CVSI's latest filing, from $47000.0 in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $626000.0 in Q1 2022 and troughed at $47000.0 in Q3 2025.
- A 5-year average of $294187.5 and a median of $270000.0 in 2023 frame the typical range for Other Non-Current Assets.
- The sharpest annual moves came in 2022 and 2025: Other Non-Current Assets rose 24.95% in 2022, then tumbled 69.48% in 2025.
- Over 5 years, Other Non-Current Assets stood at $505000.0 in 2022, then tumbled by 41.39% to $296000.0 in 2023, then tumbled by 47.97% to $154000.0 in 2024, then sank by 69.48% to $47000.0 in 2025, then changed by 0.0% to $47000.0 in 2026.
- According to Business Quant data, Other Non-Current Assets over the past three periods registered $47000.0, $47000.0, and $47000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | 56.35 Mn |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 1.79 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 384.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 503.80 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 239.50 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 1.06 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 59.30 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 304.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 13.00 Mn |
| 10 | CV Sciences | 3.90 Mn | 3.63 Mn | 1.45 Mn | 47,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 47,000.00 |
| Mar 31, 2026 | 47,000.00 |
| Dec 31, 2025 | 47,000.00 |
| Sep 30, 2025 | 47,000.00 |
| Jun 30, 2025 | 72,000.00 |
| Mar 31, 2025 | 99,000.00 |
| Sep 30, 2024 | 154,000.00 |
| Jun 30, 2024 | 202,000.00 |
| Mar 31, 2024 | 244,000.00 |
| Dec 31, 2023 | 296,000.00 |
| Sep 30, 2023 | 348,000.00 |
| Jun 30, 2023 | 401,000.00 |
| Mar 31, 2023 | 452,000.00 |
| Dec 31, 2022 | 505,000.00 |
| Sep 30, 2022 | 557,000.00 |
| Jun 30, 2022 | 610,000.00 |
| Mar 31, 2022 | 626,000.00 |
| Dec 31, 2021 | 678,000.00 |
| Sep 30, 2021 | 730,000.00 |
| Jun 30, 2021 | 501,000.00 |